Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NovoCure ( (NVCR) ) just unveiled an update.
On January 30, 2026, Novocure Inc. disclosed that CMS had revoked its billing privileges for the company’s products, retroactive to December 17, 2025, due to an administrative issue with its triannual re-validation rather than any substantive failure to qualify. While Novocure has submitted a Corrective Action Plan and continues to treat existing and new patients, it cannot bill Medicare, Medicare Advantage and other CMS-related payors during the revocation period and estimates that it will be unable to recognize roughly $13 million in monthly revenue from these payors until billing privileges are restored, with the timing, ultimate resolution and extent of recoverable revenue for services rendered in the interim remaining uncertain.
The most recent analyst rating on (NVCR) stock is a Buy with a $27.00 price target. To see the full list of analyst forecasts on NovoCure stock, see the NVCR Stock Forecast page.
Spark’s Take on NVCR Stock
According to Spark, TipRanks’ AI Analyst, NVCR is a Neutral.
NovoCure’s overall stock score is primarily impacted by its financial challenges, including negative profitability and high leverage. While there are positive developments, such as international expansion and regulatory approvals, these are offset by operational inefficiencies and valuation concerns. The technical indicators suggest a lack of strong momentum, further contributing to the moderate score.
To see Spark’s full report on NVCR stock, click here.
More about NovoCure
Novocure Inc. is a U.S. subsidiary of Novocure, operating in the medical technology and healthcare sector, providing products and services to patients that are reimbursed by Medicare, Medicare Advantage and other programs administered by the Centers for Medicare & Medicaid Services (CMS).
Average Trading Volume: 1,519,144
Technical Sentiment Signal: Sell
Current Market Cap: $1.29B
Learn more about NVCR stock on TipRanks’ Stock Analysis page.